论文部分内容阅读
目的:对比分析痰热清与更昔洛韦佐治小儿支气管肺炎临床治疗效果。方法:选取我院于2010年7月到2013年4月收治的44例小儿支气管肺炎患儿,将其随机划分为三组,其中痰热清组15例,更昔洛韦组13例,参照组16例,采用常规抗生素治疗。2个实验患儿在常规抗生素治疗基础上增加使用痰热清和更昔洛韦,对患儿实施静脉滴注,对比三组患儿的肺部体征、咳嗽以及发热病症消失时间。结果:更昔洛韦组与痰热清组两组患儿的肺部啰音、咳嗽、发热等消失时间显著少于参照组,两实验组临床病症变化,对比有统计学意义(P<0.05),痰热清组的发热消失时间与更昔洛韦组对比无明显差异,对比无统计学意义(P>0.05)。三组对比差异显著,有统计学意义(P<0.05)。结论:在常规治疗基础上,给予患儿痰热清与更昔洛韦佐治疗小儿支支气管肺炎,可迅速患儿患儿临床病症,减少患儿住院时间,两种药物治疗效果相比,痰热清的治疗效果更为显著。
Objective: To compare and analyze the clinical effects of Tanreqingwei and ganciclovir in children with bronchopneumonia. Methods: Forty-four children with bronchial pneumonia admitted to our hospital from July 2010 to April 2013 were randomly divided into three groups, including 15 cases in Tanreqing group and 13 cases in Ganciclovir group. Group of 16 cases, the use of conventional antibiotics. Two experimental children in the conventional antibiotic treatment based on the increase in the use of phlegm and ganciclovir, intravenous infusion of children to compare the three groups of children with signs of the lungs, cough and fever disappear time. Results: The disappearance time of lung rales, cough and fever in ganciclovir group and Tanreqing group were significantly less than those in the reference group. The clinical symptoms of the two experimental groups were statistically significant (P <0.05 ), There was no significant difference in the disappearance of fever between Tanreqing group and ganciclovir group (P> 0.05). The difference between the three groups was significant, with statistical significance (P <0.05). Conclusion: On the basis of routine treatment, the patients given Tanrelor Wei and Ganciclovir treatment of bronchial pneumonia in children with bronchial pneumonia can be rapidly in children with clinical symptoms and reduce hospitalization time, the two drugs compared to the effect of sputum Heat-clearing treatment is more pronounced.